066700 — THERAGEN ETEX CO Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Market Cap
KR₩104bn
Enterprise Value
KR₩130bn
Revenue
KR₩250bn

Annual balance sheet for THERAGEN ETEX CO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,832	13,602	21,421	23,280	24,183
Net Total Accounts Receivable
Net Total Receivables	59,691	58,779	62,298	67,409	67,653
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	96,337	96,954	106,962	115,390	150,714
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	42,461	40,695	41,422	41,653	46,789
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	534,886	350,073	246,553	243,135	237,003
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	65,240	74,693	74,839	85,721	100,419
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	160,764	127,377	102,955	107,434	124,857
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	374,121	222,697	143,598	135,701	112,146
Total Liabilities & Shareholders' Equity	534,886	350,073	246,553	243,135	237,003
Total Common Shares Outstanding